Ionis Pharmaceuticals Inc (IONS) Chairman & CEO Stanley T Crooke Sold $702,500 of Shares (Guru Focus)
Chairman & CEO of Ionis Pharmaceuticals Inc (30-Year Financial, Insider Trades) Stanley T Crooke (insider trades) sold 10,000 shares of IONS on 07/18/2019 at an average price of $70.25 a share. The total sale was $702,500. Ionis Pharmaceuticals Inc is the RNA-targeted drug discovery and development company. Its broad pipeline consists of close to 32 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe, and rare diseases. Ionis Pharmaceuticals Inc has a market cap of $9.67 billion; its shares were traded at around $68.88 with a P/E ratio of 27.43 and P/S ratio of 12.75. GuruFocus has detected 2 severe warning signs with Ionis Pharmaceuticals Inc.
Tuesday 7/23 Insider Buying Report: BK, TSC (Nasdaq.com)
At Bank of New York Mellon Corp (BK), a filing with the SEC revealed that on Thursday, Vice Chairman William M. Daley bought 11,350 shares of BK, for a cost of $44.93 each, for a total investment of $509,921. Daley was up about 3.2% on the purchase at the high point of today’s trading session, with BK trading as high as $46.38 in trading on Tuesday. Bank of New York Mellon Corp is trading up about 0.9% on the day Tuesday. This purchase marks the first one filed by Daley in the past year. And on Friday, Director James J. Dolan bought $98,850 worth of TriState Capital Holdings (TSC), buying 5,000 shares at a cost of $19.77 a piece. Before this latest buy, Dolan made one other buy in the past year, purchasing $195,800 shares at a cost of $24.48 a piece. TriState Capital Holdings is trading up about 2.2% on the day Tuesday. Dolan was up about 3.4% on the buy at the high point of today’s trading session, with TSC trading as high as $20.44 in trading on Tuesday.
Insider Activity: Wintrust Financial Corp (WTFC) Board Member Buys $50k in Stock (Investors Observer)
Gary D Sweeney, a member of the board of directors at Wintrust Financial Corp (WTFC), bought 747 shares of the company’s common stock on Jul 19. At $66.92 per share, Sweeney paid a total of $49,989 for the new shares.
Taking Insider Trading Too Far: What’s Left of the ‘Personal Benefit’ Requirement After ‘U.S. v. Martoma’? (Law.com)
On June 21, 2019, Judge Paul G. Gardephe of the Southern District of New York vacated the guilty plea of Richard Lee, a former manager at SAC Capital. Lee had pleaded guilty in 2013 to insider trading, related to the purchase of Yahoo stock based on insider tips about imminent collaboration between Yahoo and Microsoft. Judge Gardephe vacated Lee’s guilty plea because his plea allocution did not establish his knowledge of any “personal benefit” that corporate insiders received as a result of providing him with this confidential information. Judge Gardephe concluded that “under the unusual circumstances of this case,” namely the fact that the personal benefit test had been changed so drastically by the Second Circuit and the Supreme Court between Lee’s plea and sentencing, his plea could not stand. Unfortunately for Lee, however, it is too early to celebrate.
Impinj Inc (PI) CEO Chris Ph.d. Diorio Sold $614,005 of Shares (Guru Focus)
CEO of Impinj Inc (30-Year Financial, Insider Trades) Chris Ph.d. Diorio (insider trades) sold 17,543 shares of PI on 07/22/2019 at an average price of $35 a share. The total sale was $614,005. Impinj Inc provides radio frequency identification solutions. The company’s software includes – ItemSense. Impinj Inc has a market cap of $721.260 million; its shares were traded at around $33.35 with and P/S ratio of 5.54. GuruFocus has detected 3 severe warning signs with Impinj Inc.
The EVP, Operations of Schlumberger Limited (NYSE: SLB) is Selling Shares (Analyst Ratings)
Today, the EVP, Operations of Schlumberger Limited (SLB), Mogharbel Khaled Al, sold shares of SLB for $583K. SLB’s market cap is $53.62B and the company has a P/E ratio of 25.76. Currently, Schlumberger Limited has an average volume of 10.96M. Based on 8 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $48.67, reflecting a 23.2% upside. The insider sentiment on Schlumberger Limited has been negative according to 98 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
